Inflammaging Attenuation is the active therapeutic reduction of the chronic, low-grade, systemic inflammatory state that progressively develops with advancing chronological age. This persistent, non-resolving inflammation is a recognized hallmark of aging that drives numerous degenerative processes. Attenuation implies a deliberate clinical effort to suppress these pro-inflammatory signals. We target this chronic state because it compromises tissue function and hormonal signaling fidelity.
Origin
The term originates from the convergence of immunology and gerontology, specifically defining the persistent inflammatory phenotype seen in older organisms. Clinical application seeks to reverse this detrimental, age-associated baseline.
Mechanism
Attenuation mechanisms focus on suppressing key inflammatory mediators such as NF-κB signaling pathways or reducing the burden of senescent cells which secrete pro-inflammatory cytokines. Furthermore, optimizing anabolic hormones often indirectly reduces systemic inflammation by improving metabolic efficiency. This ultimately supports a healthier cellular microenvironment less prone to chronic pathology.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.